These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 25789628

  • 21. Macrophage activation marker soluble CD163 and non-alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery.
    Kazankov K, Tordjman J, Møller HJ, Vilstrup H, Poitou C, Bedossa P, Bouillot JL, Clement K, Grønbaek H.
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1293-300. PubMed ID: 25772748
    [Abstract] [Full Text] [Related]

  • 22. Expression of CD206 and CD163 on intermediate CD14++CD16+ monocytes are increased in hemorrhagic fever with renal syndrome and are correlated with disease severity.
    Li X, Du N, Xu G, Zhang P, Dang R, Jiang Y, Zhang K.
    Virus Res; 2018 Jul 15; 253():92-102. PubMed ID: 29857122
    [Abstract] [Full Text] [Related]

  • 23. Serum soluble CD163 levels in patients with influenza-associated encephalopathy.
    Hasegawa S, Matsushige T, Inoue H, Takahara M, Kajimoto M, Momonaka H, Ishida C, Tanaka S, Morishima T, Ichiyama T.
    Brain Dev; 2013 Aug 15; 35(7):626-9. PubMed ID: 23149357
    [Abstract] [Full Text] [Related]

  • 24. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
    Baeten D, Møller HJ, Delanghe J, Veys EM, Moestrup SK, De Keyser F.
    Arthritis Rheum; 2004 May 15; 50(5):1611-23. PubMed ID: 15146432
    [Abstract] [Full Text] [Related]

  • 25. Downregulation of CD163 in monocytes and its soluble form in the plasma is associated with a pro-inflammatory profile in pregnant women with preeclampsia.
    Nunes PR, Romão-Veiga M, Peraçoli JC, Araujo Costa RA, de Oliveira LG, Borges VTM, Peraçoli MT.
    Immunol Res; 2019 Jun 15; 67(2-3):194-201. PubMed ID: 31240481
    [Abstract] [Full Text] [Related]

  • 26. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
    Nakayama W, Jinnin M, Makino K, Kajihara I, Makino T, Fukushima S, Sakai K, Inoue Y, Ihn H.
    Eur J Dermatol; 2012 Jun 15; 22(4):512-7. PubMed ID: 22576016
    [Abstract] [Full Text] [Related]

  • 27. Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
    Fabriek BO, Møller HJ, Vloet RP, van Winsen LM, Hanemaaijer R, Teunissen CE, Uitdehaag BM, van den Berg TK, Dijkstra CD.
    J Neuroimmunol; 2007 Jul 15; 187(1-2):179-86. PubMed ID: 17537523
    [Abstract] [Full Text] [Related]

  • 28. Soluble CD163.
    Møller HJ.
    Scand J Clin Lab Invest; 2012 Feb 15; 72(1):1-13. PubMed ID: 22060747
    [Abstract] [Full Text] [Related]

  • 29. Soluble CD163 and mannose receptor associate with chronic hepatitis B activity and fibrosis and decline with treatment.
    Laursen TL, Wong GL, Kazankov K, Sandahl T, Møller HJ, Hamilton-Dutoit S, George J, Chan HL, Grønbaek H.
    J Gastroenterol Hepatol; 2018 Feb 15; 33(2):484-491. PubMed ID: 28618015
    [Abstract] [Full Text] [Related]

  • 30. New immunological serum markers in bacteraemia: anti-inflammatory soluble CD163, but not proinflammatory high mobility group-box 1 protein, is related to prognosis.
    Gaïni S, Pedersen SS, Koldkaer OG, Pedersen C, Moestrup SK, Møller HJ.
    Clin Exp Immunol; 2008 Mar 15; 151(3):423-31. PubMed ID: 18190604
    [Abstract] [Full Text] [Related]

  • 31. Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.
    Ingels C, Møller HJ, Hansen TK, Wouters PJ, Vanhorebeek I, Van den Berghe G.
    J Clin Immunol; 2013 Apr 15; 33(3):619-29. PubMed ID: 23150181
    [Abstract] [Full Text] [Related]

  • 32. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
    Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T.
    J Infect Dis; 2016 Oct 15; 214(8):1198-204. PubMed ID: 27354366
    [Abstract] [Full Text] [Related]

  • 33. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
    Bielecki M, Kowal K, Lapinska A, Chyczewski L, Kowal-Bielecka O.
    Adv Med Sci; 2013 Oct 15; 58(1):126-33. PubMed ID: 23640944
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of soluble CD163 as a marker of inflammation in psoriasis.
    Feighery C, Dunne J, Bingham EA, Feighery CF.
    Clin Exp Dermatol; 2011 Mar 15; 36(2):201-3. PubMed ID: 21323937
    [Abstract] [Full Text] [Related]

  • 35. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J, Prada A, Siegel DM, Villanueva J, Olson J, Ilowite NT, Brunner HI, Griffin T, Graham TB, Sherry DD, Passo MH, Ramanan AV, Filipovich A, Grom AA.
    Arthritis Rheum; 2007 Mar 15; 56(3):965-71. PubMed ID: 17328073
    [Abstract] [Full Text] [Related]

  • 36. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
    Møller HJ, Grønbaek H, Schiødt FV, Holland-Fischer P, Schilsky M, Munoz S, Hassanein T, Lee WM, U.S. Acute Liver Failure Study Group.
    J Hepatol; 2007 Nov 15; 47(5):671-6. PubMed ID: 17629586
    [Abstract] [Full Text] [Related]

  • 37. Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy.
    Burdo TH, Lentz MR, Autissier P, Krishnan A, Halpern E, Letendre S, Rosenberg ES, Ellis RJ, Williams KC.
    J Infect Dis; 2011 Jul 01; 204(1):154-63. PubMed ID: 21628670
    [Abstract] [Full Text] [Related]

  • 38. Levels of soluble CD163 and severity of malaria in children in Ghana.
    Kusi KA, Gyan BA, Goka BQ, Dodoo D, Obeng-Adjei G, Troye-Blomberg M, Akanmori BD, Adjimani JP.
    Clin Vaccine Immunol; 2008 Sep 01; 15(9):1456-60. PubMed ID: 18632918
    [Abstract] [Full Text] [Related]

  • 39. Increased serum levels of soluble CD163 in patients with scleroderma.
    Shimizu K, Ogawa F, Yoshizaki A, Akiyama Y, Kuwatsuka Y, Okazaki S, Tomita H, Takenaka M, Sato S.
    Clin Rheumatol; 2012 Jul 01; 31(7):1059-64. PubMed ID: 22453843
    [Abstract] [Full Text] [Related]

  • 40. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q, Ou Q, Chen H, Gao Y, Liu Y, Xu Y, Ruan Q, Zhang W, Shao L.
    BMC Infect Dis; 2019 Nov 28; 19(1):1006. PubMed ID: 31779590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.